| TARS Stock | | | USD 52.45 1.61 3.17% |
Tarsus Pharmaceuticals Price To Sales Ratio yearly trend continues to be comparatively stable with very little volatility. Price To Sales Ratio is likely to outpace its year average in 2024.
Check out the analysis of
Tarsus Pharmaceuticals Correlation against competitors.
For more information on how to buy Tarsus Stock please use our
How to Invest in Tarsus Pharmaceuticals guide.
Latest Tarsus Pharmaceuticals' Price To Sales Growth Pattern
Below is the plot of the Price To Sales Ratio of Tarsus Pharmaceuticals over the last few years. Price to Sales Ratio is figured by comparing Tarsus Pharmaceuticals stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Tarsus Pharmaceuticals sales, a figure that is much harder to manipulate than other Tarsus Pharmaceuticals multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. It is a valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period. Tarsus Pharmaceuticals' Price To Sales Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Tarsus Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 15.47 X | 10 Years Trend | | |
Tarsus Price To Sales Regression Statistics
| Arithmetic Mean | 12.08 |
| Geometric Mean | 10.22 |
| Coefficient Of Variation | 77.93 |
| Mean Deviation | 6.35 |
| Median | 8.11 |
| Standard Deviation | 9.41 |
| Sample Variance | 88.64 |
| Range | 27.7004 |
| R-Value | 0.64 |
| Mean Square Error | 55.95 |
| R-Squared | 0.41 |
| Significance | 0.01 |
| Slope | 1.35 |
| Total Sum of Squares | 1,241 |
Tarsus Price To Sales History
| 2024 | 35.81 | |
| 2023 | 34.1 | |
| 2022 | 13.98 | |
About Tarsus Pharmaceuticals Financial Statements
Tarsus Pharmaceuticals shareholders use historical fundamental indicators, such as Price To Sales, to determine how well the company is positioned to perform in the future. Although Tarsus Pharmaceuticals investors may analyze each financial statement separately, they are all interrelated. The changes in Tarsus Pharmaceuticals' assets and liabilities, for example, are also reflected in the revenues and expenses on on Tarsus Pharmaceuticals' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our
fundamental analysis page.
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Additional Tools for Tarsus Stock Analysis
When running Tarsus Pharmaceuticals' price analysis, check to
measure Tarsus Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tarsus Pharmaceuticals is operating at the current time. Most of Tarsus Pharmaceuticals' value examination focuses on studying past and present price action to
predict the probability of Tarsus Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tarsus Pharmaceuticals' price. Additionally, you may evaluate how the addition of Tarsus Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.